Author Correction: Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice

Autor: Rasmus Mortensen, Helena Strand Clemmensen, Joshua S. Woodworth, Marie Louise Therkelsen, Tehmina Mustafa, Kristian Tonby, Synne Jenum, Else Marie Agger, Anne Ma Dyrhol-Riise, Peter Andersen

Publikováno v: Communications Biology, Vol 7, Iss 1, Pp 1-1 (2024)

Externí odkaz: https://doaj.org/article/995a3f3e46fe452a9b4008f9db891344

In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection

Autor: Helena Strand Clemmensen, Jean-Yves Dube, Fiona McIntosh, Ida Rosenkrands, Gregers Jungersen, Claus Aagaard, Peter Andersen, Marcel A. Behr, Rasmus Mortensen

Publikováno v: mBio, Vol 12, Iss 2 (2021)

Tuberculosis, caused by Mtb, constitutes a global health crisis of massive proportions, and the impact of the current coronavirus disease 2019 (COVID-19) pandemic is expected to cause a rise in tuberculosis-related deaths. Improved vaccines are there

Externí odkaz: https://doaj.org/article/2ebf09603932441099af75020674a1ba

A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin

Autor: Peter Andersen, Karin Dijkman, Cecilia S. Lindestam Arlehamn, Helena Strand Clemmensen, Jeffrey Morgan, Joshua S. Woodworth, Claus Aagaard, Randy Taplitz, Ida Rosenkrands, Rasmus Mortensen, Thomas Lindenstrøm, Raquel Salvador Laureano, Hannah Battey

Publikováno v: Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Woodworth, J S, Clemmensen, H S, Battey, H, Dijkman, K, Lindenstrøm, T, Laureano, R S, Taplitz, R, Morgan, J, Aagaard, C, Rosenkrands, I, Lindestam Arlehamn, C S, Andersen, P & Mortensen, R 2021, ' A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin ', Nature Communications, vol. 12, 6658 . https://doi.org/10.1038/s41467-021-26934-0
Woodworth, J S, Clemmensen, H S, Battey, H, Dijkman, K, Lindenstrøm, T, Laureano, R S, Taplitz, R, Morgan, J, Aagaard, C, Rosenkrands, I, Lindestam Arlehamn, C S, Andersen, P & Mortensen, R 2021, ' A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin ', Nature Communications, vol. 12, no. 1, 6658 . https://doi.org/10.1038/s41467-021-26934-0
Nature Communications

Given the encouraging clinical results of both candidate subunit vaccines and revaccination with Bacillus Calmette-Guérin (BCG) against tuberculosis (TB), there is support for combining BCG and subunit vaccination for increased efficacy. BCG and Myc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfcb2b1817a2d2f1c703346a5307dc1d
https://doaj.org/article/e8cde506edf04ab4beac2a4d5130dcb7

In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection

Autor: Fiona McIntosh, Gregers Jungersen, Marcel A. Behr, Ida Rosenkrands, Peter Bach Andersen, Rasmus Mortensen, Claus Aagaard, Helena Strand Clemmensen, Jean Yves Dube

Publikováno v: mBio, Vol 12, Iss 2 (2021)
Clemmensen, H S, Dube, J Y, McIntosh, F, Rosenkrands, I, Jungersen, G, Aagaard, C, Andersen, P, Behr, M A & Mortensen, R 2021, ' In vivo antigen expression regulates cd4 t cell differentiation and vaccine efficacy against mycobacterium tuberculosis infection ', mBio, vol. 12, no. 2, e00226-21 . https://doi.org/10.1128/mBio.00226-21
bioRxiv
article-version (status) pre
article-version (number) 1
Clemmensen, H S, Dube, J Y, McIntosh, F, Rosenkrands, I, Jungersen, G, Aagaard, C, Andersen, P, Behr, M A & Mortensen, R 2021, ' In vivo antigen expression regulates CD4 T cell differentiation and vaccine efficacy against mycobacterium tuberculosis infection ', mBio (Online), vol. 12, no. 2, e00226-21 . https://doi.org/10.1128/mBio.00226-21
mBio

Tuberculosis, caused by Mtb, constitutes a global health crisis of massive proportions, and the impact of the current coronavirus disease 2019 (COVID-19) pandemic is expected to cause a rise in tuberculosis-related deaths. Improved vaccines are there

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aecb561e188f67e7f6c1a40391b5185
https://journals.asm.org/doi/10.1128/mBio.00226-21

A novel Mycobacterium tuberculosis-specific subunit vaccine provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin

Autor: Helena Strand Clemmensen, Peter Andersen, Karin Dijkman, Jeffrey Morgan, Randy Taplitz, Cecilia S. Lindestam Arlehamn, Joshua S. Woodworth, Thomas Lindenstrøm, Raquel Salvador Laureano, Rasmus Mortensen, Claus Aagaard, Ida Rosenkrands, Hannah Battey

Tuberculosis (TB) remains a global health crisis. Following encouraging clinical results of subunit vaccination and revaccination with Bacillus Calmette-Guérin (BCG), it has been suggested to combine BCG and subunit vaccines for increased efficacy.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::07f96b70a7c38c6ac60714a591d62971
https://doi.org/10.1101/2021.03.18.435784